Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust JSE LIMITED (Incorporated in the Republic of South Africa) Registration number: 2005/022939/06 Share Code: JSE ISIN Code: ZAE000079711 LEI: 213800MZ1VUQEBWRFO39 ("JSE") DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY SECRETARY AND THE JSE LTIS 2018 TRUST The JSE LTIS 2018 Trust ("Trust") has acquired 494 170 JSE ordinary shares in the open market on behalf of executive directors, members of the executive committee, the Company Secretary and senior members of staff ("LTIS 2018 participants") to fulfil share awards granted in March 2020 to these staff under the JSE’s Long-Term Incentive Scheme ("LTIS 2018"). These ordinary shares are held in trust and are restricted until all vesting criteria are fulfilled whereupon the shares vest. To the extent that the vesting criteria are not fulfilled the share awards are forfeited. The vesting of these restricted JSE ordinary shares is subject to – (i) the JSE achieving specified corporate performance targets over the measurement period; and (ii) a LTIS 2018 participant remaining in the employ of the JSE for the vesting term (collectively "the vesting criteria"). These JSE ordinary shares were acquired on-market, with prior clearance, at a volume-weighted average price of R102.7343 per ordinary share. The total transaction value amounted to R50 768 209.03. The daily high, low and volume-weighted average for the various transactions were – Dates in 2020 Daily VWAP of that JSE Number of JSE JSE shares Daily high Daily low ordinary ordinary acquired price paid price paid shares shares (cents per (cents per (cents per acquired acquired share) share) share) 11 March 20 040 10389.56 10523 10290 12 March 182 066 10215.35 10322 9900 13 March 216 818 10524.00 10838 10059 16 March 75 246 9661.02 10235 9291 The requisite approvals have been granted by shareholders at the JSE’s annual general meeting, in respect of the acquisition of JSE ordinary shares in the open market and in respect of specific financial assistance to the Trust for the purpose of acquiring these shares. ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, THE COMPANY SECRETARY AND PRESCRIBED OFFICERS Following the acquisition of the JSE ordinary shares by the Trust as disclosed above, the executive directors, members of the executive committee and the Company Secretary have on 13 March 2020 accepted grants of restricted JSE ordinary shares, as reflected in this announcement. Total number of restricted Total Rand value JSE ordinary of restricted JSE shares ordinary shares awarded and awarded and Nature of Executive Role accepted accepted interest Group CEO & Executive Direct L Fourie Director 84 570 8 688 240 beneficial CFO & Executive Direct A Takoordeen Director 24 916 2 559 728 beneficial Prescribed Direct A Greenwood Officer 26 506 2 723 075 beneficial Prescribed Direct D Khumalo Officer 19 668 2 020 578 beneficial Prescribed Direct H Kotze Officer 22 962 2 358 985 beneficial Prescribed Direct Z Morrison Officer 16 060 1 649 913 beneficial Prescribed Direct M Randall Officer 20 754 2 132 148 beneficial Prescribed Direct V Reddy Officer 23 918 2 457 199 beneficial Group Company Direct GA Brookes Secretary 11 794 1 211 648 beneficial The restricted shares will vest in two tranches, one-half on 1 March 2023 and the remaining half on 1 March 2024, subject to the vesting criteria as set out above being met. The individual allocations (grant and acceptance) were approved by the JSE’s Group Human Resources Committee and clearance to deal was granted by the Chairman of the Board. Sandton 17 March 2020 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 17-03-2020 05:24:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.